PharmaEssentia (TWSE: 6446) today announced its net revenues for March 2025: On a consolidated basis, revenues for March 2025 were approximately NT$1.18 billion, an increase of 15.55% from February 2025 and an increase of 111.51% from March 2024. The year-to-date consolidated revenue totaled NT$3.26 billion, an increase of 97.00%.